Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

JSPRJasper Therapeutics, Inc.

Nasdaq · CIK 0001788028
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts477

Identity from submissions API

NameJasper Therapeutics, Inc.
CIK0001788028
TickersJSPR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN842984849
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone6505491400
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Amplitude Healthcare Acquisition Corp (2019-09-13T04:00:00.000Z → 2021-09-29T04:00:00.000Z)
Business address
2200 BRIDGE PKWY SUITE #102
REDWOOD CITY
CA
94065
CA
Mailing address
2200 BRIDGE PKWY SUITE #102
REDWOOD CITY
CA
94065
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

489 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005239 005-91228 261558028 34 10485
2026-11-16 10-Q QUARTERLY REPORT 0001213900-26-120161 001-39138 261555572 34 9325261 1 1
2026-11-16 8-K CURRENT REPORT 2.02,9.01 0001213900-26-120141 001-39138 261555534 34 305957 1 1
2026-11-13 8-K CURRENT REPORT 8.01 0001213900-26-119785 001-39138 261553179 34 188999 1 1
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000690 005-91228 261552485 34 17328
2026-11-09 8-K CURRENT REPORT 8.01,9.01 0001213900-26-117230 001-39138 261533910 34 233791 1 1
2026-11-04 8-K CURRENT REPORT 3.03,5.03,7.01,9.01 0001213900-26-115751 001-39138 261520135 34 263561 1 1
2026-10-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000538 005-91228 261495054 34 171418
2026-10-23 SC TO-I/A AMENDMENT NO. 1 TO FORM SC TO-I 0001213900-26-112090 005-91228 261482141 34 205040
2026-10-19 DEF 14A PROXY STATEMENT 0001213900-26-110751 001-39138 261470706 34 5334128
2026-10-15 8-K CURRENT REPORT 8.01,9.01 0001213900-26-109587 001-39138 261461365 34 244366 1 1
2026-10-14 S-3 REGISTRATION STATEMENT 0001213900-26-109479 333-299459 261460609 33 504079 1 1
2026-10-09 PRE 14A PROXY STATEMENT 0001213900-26-108482 001-39138 261453491 34 5334982
2026-10-07 8-K CURRENT REPORT 8.01,9.01 0001213900-26-107402 001-39138 261445496 34 238327 1 1
2026-10-07 SC TO-I FORM SC TO-I 0001213900-26-107397 005-91228 261445469 34 1038535 1 1
2026-10-05 8-K CURRENT REPORT 5.07 0001213900-26-106651 001-39138 261438812 34 201643 1 1
2026-10-05 8-K/A AMENDMENT NO. 2 TO FORM 8-K 9.01 0001213900-26-106574 001-39138 261438355 34 401875 1 1
2026-10-01 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001213900-26-105924 001-39138 261432630 34 930866 1 1
2026-09-28 8-K CURRENT REPORT 5.02 0001213900-26-104101 001-39138 261417933 34 188913 1 1
2026-09-24 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000914 001-39138 261404943 34 3214
2026-09-04 DEF 14A PROXY STATEMENT 0001213900-26-097572 001-39138 261361828 34 3769678
2026-08-26 8-K CURRENT REPORT 1.01 0001213900-26-093979 001-39138 261323134 34 245206 1 1
2026-08-24 PRE 14A PROXY STATEMENT 0001213900-26-093145 001-39138 261311752 34 3770193
2026-08-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002220 005-91228 261286741 34 46110
2026-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-26-090055 001-39138 261281432 34 336896 1 1
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-089592 001-39138 261277823 34 7070782 1 1
2026-08-05 D xslFormDX01/primary_doc.xml 06b 0001213900-26-085315 021-593140 261240655 33 12792
2026-08-04 4 xslF345X06/ownership.xml 0001213900-26-085192 6009
2026-08-04 4 xslF345X06/ownership.xml 0001213900-26-085191 5996
2026-08-04 4 xslF345X06/ownership.xml 0001213900-26-085190 21945
2026-08-04 4 xslF345X06/ownership.xml 0001213900-26-085189 6000
2026-08-04 4 xslF345X06/ownership.xml 0001213900-26-085188 6036
2026-08-03 8-K CURRENT REPORT 5.07 0001213900-26-084687 001-39138 261233857 34 247995 1 1
2026-07-31 8-K CURRENT REPORT 8.01 0001213900-26-083563 001-39138 261225257 34 244383 1 1
2026-07-23 3 xslF345X06/ownership.xml 0001213900-26-080864 20469
2026-07-22 4 xslF345X06/ownership.xml 0001213900-26-080525 6995
2026-07-22 3 xslF345X06/ownership.xml 0001213900-26-080524 28288
2026-07-22 3 xslF345X06/ownership.xml 0001213900-26-080523 21046
2026-07-20 4 xslF345X06/ownership.xml 0001213900-26-079764 9363
2026-07-20 3 xslF345X06/ownership.xml 0001213900-26-079762 5745
2026-07-20 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000921895-26-001834 005-91228 261187380 34 26915
2026-07-17 8-K CURRENT REPORT 1.01,2.01,3.02,5.02,5.03,7.01,9.01 0001213900-26-078887 001-39138 261181741 34 17913469 1 1
2026-07-16 8-K CURRENT REPORT 7.01,9.01 0001213900-26-078781 001-39138 261181192 34 290172 1 1
2026-07-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-082738 005-91228 261169675 34 19543
2026-06-15 ARS ARS 0001213900-26-068772 001-39138 261090762 34 976180
2026-06-15 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-068767 001-39138 261090728 34 3682255
2026-06-15 DEF 14A PROXY STATEMENT 0001213900-26-068765 001-39138 261090713 34 10043016 1 1
2026-06-09 8-K CURRENT REPORT 3.01 0001213900-26-066782 001-39138 261076084 34 247400 1 1
2026-06-01 8-K CURRENT REPORT 7.01,9.01 0001213900-26-063157 001-39138 261047271 34 287131 1 1
2026-05-21 8-K CURRENT REPORT 5.02,9.01 0001213900-26-060029 001-39138 261008244 34 237220 1 1
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056595 001-39138 26978754 34 5019343 1 1
2026-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-26-056596 001-39138 26978714 34 326954 1 1
2026-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000171 005-91228 26967264 34 12411
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-053990 005-91228 26959501 34 29584
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000886982-26-000153 005-91228 26957505 34 18480
2026-04-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-26-050178 001-39138 26924824 34 783403 1 1
2026-03-30 8-K CURRENT REPORT 2.02,9.01 0001213900-26-036448 001-39138 26813485 34 334489 1 1
2026-03-30 10-K ANNUAL REPORT 0001213900-26-036426 001-39138 26813402 34 9676785 1 1
2026-02-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-019751 005-91228 26679662 34 18867
2026-02-18 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-007366 005-91228 26650356 34 20160
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000886982-26-000077 005-91228 26624094 34 18222
2026-02-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-26-000039 005-91228 26619800 34 11948
2026-02-10 4 xslF345X05/ownership.xml 0001213900-26-014244 5752
2026-01-26 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-26-000002 005-91228 26560330 34 12653
2026-01-08 8-K CURRENT REPORT 8.01,9.01 0001213900-26-002329 001-39138 26517341 34 36164504 1 1
2026-01-07 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-26-002185 001-39138 26516112 34 289927 1 1
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001385 5745
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001383 5737
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001382 5652
2025-12-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-25-000064 005-91228 251541911 34 12515
2025-12-02 8-K CURRENT REPORT 8.01,9.01 0001213900-25-116943 001-39138 251541561 34 14980407 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001765710-25-000005 005-91228 251488298 34 13188
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000546 005-91228 251483354 34 7555
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-006584 005-91228 251471268 34 14631
2025-11-10 10-Q QUARTERLY REPORT 0001213900-25-107884 001-39138 251464498 34 5995978 1 1
2025-11-10 8-K CURRENT REPORT 2.02,9.01 0001213900-25-107874 001-39138 251464449 34 357164 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000572 005-91228 251461600 34 8177
2025-09-24 4 xslF345X05/ownership.xml 0001213900-25-091105 8080
2025-09-24 4 xslF345X05/ownership.xml 0001213900-25-091104 7229
2025-09-24 4 xslF345X05/ownership.xml 0001213900-25-091099 7270
2025-09-24 4 xslF345X05/ownership.xml 0001213900-25-091096 7270
2025-09-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002600 005-91228 251334480 34 55521
2025-09-19 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-089584 001-39138 251327306 34 951017 1 1
2025-09-19 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-089581 333-285914 251327292 33 800433
2025-09-18 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-089025 333-285914 251324038 33 804052
2025-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-25-075678 001-39138 251211680 34 323943 1 1
2025-08-13 10-Q QUARTERLY REPORT 0001213900-25-075635 001-39138 251211282 34 5289132 1 1
2025-08-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000475 005-91228 251190373 34 7938
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003206 005-91228 251132325 34 10864
2025-07-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004068 005-91228 251118236 34 14124
2025-07-09 8-K CURRENT REPORT 2.05,5.02,8.01,9.01 0001213900-25-062194 001-39138 251112305 34 277027 1 1
2025-07-07 8-K CURRENT REPORT 8.01,9.01 0001213900-25-061632 001-39138 251106990 34 20227733 1 1
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061503 5700
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061501 5685
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061500 5721
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061498 5692
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061495 5666
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061493 5694
2025-07-03 4 xslF345X05/ownership.xml 0001213900-25-061492 5681
2025-07-03 8-K CURRENT REPORT 5.07 0001213900-25-061471 001-39138 251105498 34 255972 1 1
2025-06-16 8-K CURRENT REPORT 8.01,9.01 0001213900-25-054465 001-39138 251048487 34 19811726 1 1
2025-06-06 4 xslF345X05/ownership.xml 0001213900-25-051729 5734
2025-06-06 4 xslF345X05/ownership.xml 0001213900-25-051726 5736
2025-06-06 4 xslF345X05/ownership.xml 0001213900-25-051724 5651
2025-06-06 4 xslF345X05/ownership.xml 0001213900-25-051722 5752
2025-05-19 ARS FORM ARS 0001213900-25-045091 001-39138 25961551 34 978623
2025-05-19 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-045090 001-39138 25961544 34 3805879
2025-05-19 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-045086 001-39138 25961529 34 9767624 1 1
2025-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-25-042017 001-39138 25934671 34 352060 1 1
2025-05-12 10-Q QUARTERLY REPORT 0001213900-25-042011 001-39138 25934584 34 4725908 1 1
2025-03-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000800 333-285914 25774989 33 1866
2025-03-26 424B5 PROSPECTUS 0001013762-25-002767 333-285914 25773968 33 175457
2025-03-24 CORRESP filename1.htm 0001013762-25-001604 7212
2025-03-21 UPLOAD filename1.pdf 0000000000-25-003070 333-285914 40221
2025-03-19 8-K CURRENT REPORT 1.01,1.02,9.01 0001213900-25-025123 001-39138 25753340 34 257051 1 1
2025-03-19 S-3 REGISTRATION STATEMENT 0001213900-25-025077 333-285914 25752824 33 1341361
2025-02-28 10-K ANNUAL REPORT 0001213900-25-018384 001-39138 25683220 34 8179067 1 1
2025-02-27 8-K CURRENT REPORT 2.02,9.01 0001213900-25-017656 001-39138 25673135 34 340619 1 1
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-014951 5742
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-014950 5750
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-014949 5657
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-014948 5758
2025-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-012186 005-91228 25609658 34 31250
2025-01-08 8-K CURRENT REPORT 8.01,9.01 0001213900-25-001810 001-39138 25516568 34 18940824 1 1
2024-12-12 4 xslF345X05/ownership.xml 0001213900-24-108551 8922
2024-12-12 144 xsl144X01/primary_doc.xml 0001213900-24-108550 001-39138 241546467 33 5246
2024-11-14 SC 13G/A d11530244_13g-a.htm 0000919574-24-006774 005-91228 241464867 34 178261
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-098328 005-91228 241461051 34 192378
2024-11-08 SC 13G us4718712023_110824.txt 0002012383-24-003556 005-91228 241439690 34 13739
2024-11-07 8-K CURRENT REPORT 2.02,9.01 0001213900-24-095175 001-39138 241433230 34 338732 1 1
2024-11-07 10-Q QUARTERLY REPORT 0001213900-24-095173 001-39138 241433187 34 5295460 1 1
2024-11-04 SC 13G/A SC 13G/A 0001178913-24-003454 005-91228 241421810 34 89528
2024-10-22 SC 13G us4718712023_102224.txt 0002012383-24-001610 005-91228 241387313 34 13729
2024-10-15 8-K CURRENT REPORT 8.01,9.01 0001213900-24-087394 001-39138 241368943 34 289245 1 1
2024-09-12 4 xslF345X05/ownership.xml 0001213900-24-078214 9409
2024-09-12 144 xsl144X01/primary_doc.xml 0001213900-24-078213 001-39138 241295777 33 5280
2024-08-13 10-Q QUARTERLY REPORT 0001213900-24-067897 001-39138 241198719 34 6670637 1 1
2024-06-20 4 xslF345X05/ownership.xml 0001213900-24-053989 5675
2024-06-20 3 xslF345X02/ownership.xml 0001213900-24-053987 9323
2024-06-20 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-24-053982 001-39138 241053941 34 287652 1 1
2024-06-12 4 xslF345X05/ownership.xml 0001213900-24-052215 15724
2024-06-12 144 xsl144X01/primary_doc.xml 0001213900-24-052213 001-39138 241039884 33 5209
2024-06-12 4 xslF345X05/ownership.xml 0001213900-24-052087 17398
2024-06-12 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-24-051891 001-39138 241037513 34 678600 1 1
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051417 11348
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051416 11524
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051414 11839
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051411 11751
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051409 11708
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051405 5188
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051401 11441
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051398 11998
2024-06-07 S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050849 333-277674 241030573 33 141972
2024-06-07 S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050843 333-270361 241030533 33 141972
2024-06-07 S-8 POS POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-050838 333-263702 241030505 33 141972
2024-06-07 S-8 REGISTRATION STATEMENT 0001213900-24-050751 333-280039 241029156 33 570919
2024-05-14 10-Q QUARTERLY REPORT 0001213900-24-042805 001-39138 24942866 34 4777140 1 1
2024-05-03 DEFA14A ADDITIONAL MATERIALS 0001213900-24-039304 001-39138 24910678 34 41663
2024-04-22 ARS FORM ARS 0001213900-24-034840 001-39138 24860720 34 865684
2024-04-22 DEFA14A ADDITIONAL MATERIALS 0001213900-24-034831 001-39138 24860670 34 3755792
2024-04-22 DEF 14A PROXY STATEMENT 0001213900-24-034820 001-39138 24860614 34 5437176
2024-03-27 SC 13G d11006439_13g.htm 0000919574-24-002193 005-91228 24791139 34 226429
2024-03-12 4 xslF345X05/ownership.xml 0001213900-24-021961 10097
2024-03-12 144 xsl144X01/primary_doc.xml 0001213900-24-021952 001-39138 24744275 33 4590
2024-03-06 144 xsl144X01/primary_doc.xml 0001972362-24-000339 001-39138 24727334 33 4349
2024-03-05 S-8 REGISTRATION STATEMENT 0001213900-24-020154 333-277674 24721697 33 96785
2024-03-05 10-K ANNUAL REPORT 0001213900-24-020114 001-39138 24720182 34 8864224 1 1
2024-03-04 8-K CURRENT REPORT 2.02,9.01 0001213900-24-019249 001-39138 24712860 34 391490 1 1
2024-02-20 4 xslF345X05/ownership.xml 0001213900-24-015465 5718
2024-02-20 4 xslF345X05/ownership.xml 0001213900-24-015462 5724
2024-02-20 4 xslF345X05/ownership.xml 0001213900-24-015459 5639
2024-02-20 4 xslF345X05/ownership.xml 0001213900-24-015457 5748
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024111 005-91228 24641183 34 138088
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023696 005-91228 24638601 34 115284
2024-02-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000442 005-91228 24633219 34 266292
2024-02-12 4 4 0000950170-24-014017 41237
2024-02-12 SC 13D/A SC 13D/A 0001193125-24-032344 005-91228 24621730 34 200438
2024-02-09 4 OWNERSHIP DOCUMENT 0000921895-24-000337 22116
2024-02-09 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-24-000336 005-91228 24617079 34 294826
2024-02-07 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-010661 333-271500 24601703 33 803817
2024-02-06 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-24-010267 001-39138 24598279 34 657624 1 1
2024-02-05 SC 13G/A SC 13G/A 0001178913-24-000365 005-91228 24594240 34 89073
2024-02-02 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-009375 005-91228 24589068 34 156181
2024-01-04 8-K CURRENT REPORT 3.03,5.03,9.01 0001213900-24-000980 001-39138 24509697 34 295260 1 1
2024-01-02 8-K CURRENT REPORT 7.01,9.01 0001213900-24-000056 001-39138 24500298 34 280245 1 1
2023-12-20 8-K CURRENT REPORT 5.07,9.01 0001213900-23-097100 001-39138 231499331 34 264248 1 1
2023-11-30 4 xslF345X05/ownership.xml 0001213900-23-091458 4994
2023-11-22 4 xslF345X05/ownership.xml 0001213900-23-089579 4987
2023-11-20 4 xslF345X05/ownership.xml 0001213900-23-088896 8460
2023-11-20 DEF 14A PROXY STATEMENT 0001213900-23-088825 001-39138 231423578 34 3793920
2023-11-09 PRE 14A PROXY STATEMENT 0001213900-23-085198 001-39138 231392142 34 3795227
2023-11-09 10-Q QUARTERLY REPORT 0001213900-23-084970 001-39138 231390341 34 5302444 1 1
2023-11-09 8-K CURRENT REPORT 2.02,9.01 0001213900-23-084938 001-39138 231390155 34 383576 1 1
2023-11-02 4 xslF345X05/ownership.xml 0001213900-23-082883 5480
2023-11-02 3 xslF345X02/ownership.xml 0001213900-23-082881 11345
2023-11-01 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-23-081941 001-39138 231366622 34 295445 1 1
2023-10-20 8-K CURRENT REPORT 3.01 0001013762-23-005230 001-39138 231335906 34 264327 1 1
2023-10-13 4 xslF345X05/ownership.xml 0001013762-23-003903 4960
2023-10-13 4 xslF345X05/ownership.xml 0001013762-23-003902 4952
2023-10-13 4 xslF345X05/ownership.xml 0001013762-23-003901 5380
2023-10-13 144 xsl144X01/primary_doc.xml 0001013762-23-003900 001-39138 231325956 33 4455
2023-10-10 SC 13G SC 13G 0001178913-23-003298 005-91228 231316615 34 93232
2023-10-10 8-K CURRENT REPORT 7.01,9.01 0001213900-23-081286 001-39138 231315598 34 10483563 1 1
2023-10-10 8-K CURRENT REPORT 7.01,9.01 0001213900-23-081265 001-39138 231315517 34 285868 1 1
2023-09-26 4 xslF345X05/ownership.xml 0001213900-23-079569 5561
2023-09-26 3 xslF345X02/ownership.xml 0001213900-23-079563 9936
2023-09-25 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-23-078927 001-39138 231273149 34 287029 1 1
2023-09-21 8-K CURRENT REPORT 7.01,9.01 0001213900-23-078145 001-39138 231267779 34 290035 1 1
2023-08-11 S-8 REGISTRATION STATEMENT 0001213900-23-066283 333-273941 231164737 33 103429
2023-08-11 10-Q QUARTERLY REPORT 0001213900-23-066234 001-39138 231164067 34 5201784 1 1
2023-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-23-066233 001-39138 231164017 34 349227 1 1
2023-06-20 4 xslF345X04/ownership.xml 0001213900-23-050220 5615
2023-06-20 3 xslF345X02/ownership.xml 0001213900-23-050219 9816
2023-06-20 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-23-050029 001-39138 231024958 34 309835 1 1
2023-06-13 144 xsl144X01/primary_doc.xml 0001213900-23-048688 001-39138 231012802 33 4511
2023-06-13 4 xslF345X04/ownership.xml 0001213900-23-048683 9513
2023-06-13 4 xslF345X04/ownership.xml 0001213900-23-048681 5661
2023-06-13 3 xslF345X02/ownership.xml 0001213900-23-048680 9327
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047574 5219
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047573 5263
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047571 5238
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047570 5274
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047569 5245
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047568 5256
2023-06-08 4 xslF345X04/ownership.xml 0001213900-23-047567 5261
2023-06-08 8-K CURRENT REPORT 5.02,5.03,5.07,9.01 0001213900-23-047446 001-39138 231001852 34 430264 1 1
2023-06-02 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-23-045834 001-39138 23989984 34 8424805 1 1
2023-05-12 10-Q QUARTERLY REPORT 0001213900-23-039021 001-39138 23915768 34 4805387 1 1
2023-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-23-038997 001-39138 23915551 34 355843 1 1
2023-05-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-05 16:30:00 9999999995-23-001326 333-271500 23895715 33 1824
2023-05-05 424B5 PROSPECTUS 0001213900-23-036926 333-271500 23894557 33 210635
2023-05-03 CORRESP filename1.htm 0001213900-23-036051 7704
2023-05-02 UPLOAD filename1.pdf 0000000000-23-004531 40356
2023-04-28 S-3 REGISTRATION STATEMENT 0001213900-23-033846 333-271500 23865687 33 1191937
2023-04-21 ARS FORM ARS 0001213900-23-031678 001-39138 23836337 34 2590853
2023-04-21 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-031676 001-39138 23836295 34 988929
2023-04-21 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-031673 001-39138 23836259 34 1155337
2023-04-14 144 xsl144X01/primary_doc.xml 0001972362-23-000012 001-39138 23821485 33 4229
2023-04-14 4 xslF345X04/ownership.xml 0001213900-23-029901 4939
2023-04-14 4 OWNERSHIP DOCUMENT 0001213900-23-029900 4946
2023-04-14 4 OWNERSHIP DOCUMENT 0001213900-23-029896 4977
2023-04-14 4 OWNERSHIP DOCUMENT 0001213900-23-029893 5074
2023-04-14 4 xslF345X04/ownership.xml 0001213900-23-029888 4930
2023-04-14 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-23-029872 001-39138 23821139 34 285620 1 1
2023-04-13 144 xsl144X01/primary_doc.xml 0001972362-23-000008 001-39138 23819170 33 4217
2023-04-13 144 xsl144X01/primary_doc.xml 0001972362-23-000003 001-39138 23818060 33 4202
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024058 9772
2023-04-10 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-23-028579 001-39138 23811122 34 1153703
2023-03-20 4 PRIMARY DOCUMENT 0001213900-23-021494 5776
2023-03-20 4 PRIMARY DOCUMENT 0001213900-23-021493 5705
2023-03-08 S-8 REGISTRATION STATEMENT 0001213900-23-018584 333-270361 23716694 33 115881
2023-03-08 10-K ANNUAL REPORT 0001213900-23-018542 001-39138 23716239 34 8278022 1 1
2023-03-08 8-K CURRENT REPORT 2.02,9.01 0001213900-23-018537 001-39138 23716161 34 366248 1 1
2023-02-27 3/A xslF345X02/ownership.xml 0001213900-23-014976 3916
2023-02-27 SC 13D SCHEDULE 13D 0000921895-23-000611 005-91228 23674732 34 326388
2023-02-17 4 xslF345X03/ownership.xml 0001213900-23-012598 5538
2023-02-17 3 xslF345X02/ownership.xml 0001213900-23-012597 9151
2023-02-17 8-K CURRENT REPORT 5.02,5.03,7.01,8.01,9.01 0001213900-23-012596 001-39138 23640367 34 528274 1 1
2023-02-16 8-K CURRENT REPORT 7.01,9.01 0001213900-23-012446 001-39138 23638548 34 283377 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020827 005-91228 23622797 34 137039
2023-02-13 SC 13G/A SC 13G/A 0001104659-23-019776 005-91228 23619363 34 65533
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032630 005-91228 23612195 34 27707
2023-02-06 SC 13G THE SCHEDULE 13G 0000921895-23-000300 005-91228 23591238 34 285655
2023-02-03 3 OWNERSHIP DOCUMENT 0000921895-23-000278 25583
2023-02-03 4 xslF345X03/ownership.xml 0001213900-23-007992 5607
2023-01-31 4 FORM 4 SUBMISSION 0000899243-23-003059 20750
2023-01-31 SC 13D/A SC 13D/A 0001193125-23-020358 005-91228 23572749 34 190699
2023-01-30 SC 13G SC 13G 0001193125-23-019178 005-91228 23568716 34 106939
2023-01-27 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000214 005-91228 23564004 34 280159
2023-01-27 8-K CURRENT REPORT 8.01,9.01 0001213900-23-005582 001-39138 23561412 34 282568 1 1
2023-01-26 4 OWNERSHIP DOCUMENT 0001104659-23-007094 7702
2023-01-25 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-23-005155 001-39138 23552933 34 597652 1 1
2023-01-25 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-005150 333-267777 23552906 33 840549
2023-01-24 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-004850 333-267777 23548408 33 853299
2023-01-24 8-K CURRENT REPORT 7.01,9.01 0001213900-23-004843 001-39138 23548380 34 12447188 1 1
2023-01-19 8-K CURRENT REPORT 8.01,9.01 0001213900-23-003597 001-39138 23535945 34 256974 1 1
2023-01-13 8-K CURRENT REPORT 7.01,9.01 0001213900-23-002591 001-39138 23527296 34 297631 1 1
2023-01-10 8-K CURRENT REPORT 7.01,9.01 0001213900-23-001835 001-39138 23519703 34 6115612 1 1
2022-11-10 8-K CURRENT REPORT 8.01,9.01 0001213900-22-071292 001-39138 221378352 34 273978 1 1
2022-11-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-22-071291 333-267777 221378348 33 818042
2022-11-10 10-Q QUARTERLY REPORT 0001213900-22-071165 001-39138 221377197 34 6192477 1 1
2022-11-10 8-K CURRENT REPRT 2.02,9.01 0001213900-22-071153 001-39138 221377062 34 336398 1 1
2022-11-04 8-K CURRENT REPORT 3.01 0001213900-22-069368 001-39138 221362242 34 256122 1 1
2022-10-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-10-18 16:30:00 9999999995-22-003076 333-267777 221317151 33 1825
2022-10-18 424B3 PROSPECTUS 0001213900-22-064405 333-260306 221314536 33 430522
2022-10-14 CORRESP filename1.htm 0001213900-22-064076 7890
2022-10-13 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-22-062795,2022-10-13 9999999995-22-003029 333-260306 221310171 33 1838
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063949 4969
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063947 4960
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063945 5202
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063943 4973
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063941 5064
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063938 4942
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063936 4953
2022-10-13 4 xslF345X03/ownership.xml 0001213900-22-063934 4958
2022-10-13 UPLOAD filename1.pdf 0000000000-22-011268 40324
2022-10-07 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-22-062795 333-260306 221300829 33 521085
2022-10-07 S-3 REGISTRATION STATEMENT 0001213900-22-062792 333-267777 221300807 33 940319
2022-08-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-22-047390 333-260306 221160034 33 1274373
2022-08-12 10-Q QUARTERLY REPORT 0001213900-22-047382 001-39138 221159940 34 5626306 1 1
2022-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-22-047374 001-39138 221159880 34 364533 1 1
2022-08-11 3 FORM 3 SUBMISSION 0000899243-22-028389 20444
2022-08-11 SC 13D/A SC 13D/A 0001193125-22-218630 005-91228 221156587 34 228867
2022-06-28 4 xslF345X03/ownership.xml 0001213900-22-035570 7376
2022-06-27 8-K CURRENT REPORT 5.07,9.01 0001213900-22-035178 001-39138 221044489 34 262111 1 1
2022-05-12 424B3 PROSPECTUS SUPPLEMENT NO. 1 0001213900-22-025949 333-260306 22917994 33 1189711
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025945 001-39138 22917899 34 5292160 1 1
2022-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-22-025933 001-39138 22917726 34 329002 1 1
2022-04-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-022712 001-39138 22875109 34 30010
2022-04-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-022704 001-39138 22875042 34 4267918
2022-04-28 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-022301 005-91228 22867053 34 74026
2022-04-27 8-K CURRENT REPORT 7.01,9.01 0001213900-22-021894 001-39138 22859427 34 4861007 1 1
2022-04-08 4 xslF345X03/ownership.xml 0001213900-22-018928 5692
2022-04-01 424B3 PROSPECTUS 0001213900-22-017515 333-260306 22799232 33 13785003
2022-03-29 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-22-014845,2022-03-29 9999999995-22-000752 333-260306 22783084 33 1837
2022-03-24 POS AM POST EFFECTIVE REGISTRATION STATEMENT 0001213900-22-014845 333-260306 22766561 33 30186178 1 1
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014572 5596
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014570 5579
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014569 6947
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014568 5670
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014567 5590
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014565 8065
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014564 5561
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014562 12480
2022-03-23 4 xslF345X03/ownership.xml 0001213900-22-014561 5577
2022-03-23 4 xslF345X03/jasper_fm4mar212022.xml 0000905718-22-000484 7740
2022-03-22 S-8 REGISTRATION STATEMENT 0001213900-22-014221 333-263773 22760801 33 312265
2022-03-21 3 xslF345X02/ownership.xml 0001213900-22-013883 9209
2022-03-21 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-22-013743 001-39138 22754280 34 286069 1 1
2022-03-18 S-8 REGISTRATION STATEMENT 0001213900-22-013605 333-263702 22752953 33 221172
2022-03-18 10-K ANNUAL REPORT 0001213900-22-013592 001-39138 22752734 34 11401110 1 1
2022-03-18 8-K CURRENT REPORT 2.02,9.01 0001213900-22-013584 001-39138 22752571 34 342826 1 1
2022-03-16 8-K CURRENT REPORT 5.02,9.01 0001213900-22-012935 001-39138 22744836 34 382897 1 1
2022-03-16 8-K CURRENT REPORT 7.01,9.01 0001213900-22-012682 001-39138 22743216 34 1992322 1 1
2022-03-11 8-K CURRENT REPORT 5.02,9.01 0001213900-22-011854 001-39138 22733039 34 302753 1 1
2022-02-28 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-22-009585 001-39138 22683966 34 376056 1 1
2022-02-25 8-K CURRENT REPORT 7.01,9.01 0001213900-22-009272 001-39138 22673629 34 296674 1 1
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-040222 005-91228 22626816 34 40135
2022-02-14 SC 13G/A JASPER THERAPEUTICS, INC. 0001104659-22-021372 005-91228 22624895 34 140047
2022-02-11 SC 13G/A amch13ga.htm 0000935836-22-000098 005-91228 22622444 34 67281
2022-02-03 SC 13G/A formsc13ga.htm 0001493152-22-003080 005-91228 22587643 34 184104
2021-11-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-21-058780 333-260306 211404838 33 2222142
2021-11-12 10-Q QUARTERLY REPORT 0001213900-21-058660 001-39138 211403321 34 8073429 1 1
2021-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-21-058658 001-39138 211403209 34 334047 1 1
2021-10-29 424B3 PROSPECTUS SUPPLEMENT 0001213900-21-055432 333-260306 211363360 33 82073
2021-10-29 8-K CURRENT REPORT 5.02,9.01 0001213900-21-055431 001-39138 211363345 34 305419 1 1
2021-10-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-10-26 16:00:00 9999999995-21-004047 333-260306 211350518 33 1825
2021-10-26 424B3 PROSPECTUS 0001213900-21-054629 333-260306 211348769 33 18913964
2021-10-22 CORRESP filename1.htm 0001213900-21-054174 13555
2021-10-22 UPLOAD filename1.pdf 0000000000-21-012838 40314
2021-10-18 S-1 REGISTRATION STATEMENT 0001213900-21-053099 333-260306 211326946 33 49495075 1 1
2021-10-04 SC 13G SCHEDULE 13G 0001013762-21-000084 005-91228 211303325 34 107526
2021-10-04 SC 13D SC 13D 0000905718-21-001266 005-91228 211302815 34 73516
2021-10-04 SC 13G JASPER THERAPEUTICS, INC. 0001104659-21-122496 005-91228 211302668 34 140355
2021-10-04 SC 13G d8979895_13g.htm 0000919574-21-006093 005-91228 211302551 34 124112
2021-10-04 3 OWNERSHIP DOCUMENT 0001104659-21-122334 6547
2021-10-04 SC 13G SC 13G 0001104659-21-122325 005-91228 211301158 34 67605
2021-10-01 SC 13G SC 13G 0001193125-21-289912 005-91228 211300102 34 27884
2021-10-01 3 xslF345X02/jasper_fm3sep242021.xml 0000905718-21-001263 6119
2021-10-01 SC 13G SCHEDULE 13G 0001213900-21-051114 005-91228 211299040 34 93686
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051112 12698
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051111 9295
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051109 10711
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051107 11394
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051106 11345
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051105 9271
2021-10-01 3 OWNERSHIP DOCUMENT 0001213900-21-051104 12254
2021-10-01 3 OWNERSHIP DOCUMENT 0001213900-21-051103 9322
2021-10-01 3 xslF345X02/ownership.xml 0001213900-21-051101 7530
2021-09-29 8-K/A AMENDMENT NO. 1 TO FORM 8-K 3.03,5.03,5.05,9.01 0001213900-21-050602 001-39138 211292295 34 326125 1 1
2021-09-29 8-K CURRENT REPORT 1.01,2.01,3.02,4.01,5.01,5.02,5.06,7.01,9.01 0001213900-21-050592 001-39138 211292166 34 2149641 1 1
2021-09-28 4 OWNERSHIP DOCUMENT 0001213900-21-050332 11144
2021-09-28 4 xslF345X03/ownership.xml 0001213900-21-050330 11073
2021-09-28 4 xslF345X03/ownership.xml 0001213900-21-050329 11166
2021-09-28 4 OWNERSHIP DOCUMENT 0001213900-21-050322 10467
2021-09-27 25-NSE xslF25X02/primary_doc.xml 0001354457-21-001079 001-39138 211281526 34 2967
2021-09-23 8-K CURRENT REPORT 5.07,8.01,9.01 0001213900-21-049423 001-39138 211270731 34 375368 1 1
2021-09-20 425 CURRENT REPORT 0001213900-21-048848 001-39138 211263548 34 83453
2021-09-20 8-K CURRENT REPORT 8.01,9.01 0001213900-21-048846 001-39138 211263527 34 335460 1 1
2021-09-17 SC 13G amplitudehealthcare13g.htm 0000935836-21-000520 005-91228 211260997 34 69055
2021-09-09 425 CURRENT REPORT 0001213900-21-047219 001-39138 211244837 34 6144510
2021-09-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-21-047217 001-39138 211244789 34 6413154 1 1
2021-09-08 425 FORM 425 0001213900-21-047034 001-39138 211242232 34 35174
2021-08-27 SEC STAFF LETTER filename1.pdf 9999999997-21-004598 274373
2021-08-26 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2021-08-26 16:00:00 9999999995-21-003323 333-256875 211214014 33 1742
2021-08-26 424B3 PROSPECTUS 0001213900-21-045109 333-256875 211213418 33 25525144
2021-08-25 S-4/A REGISTRATION STATEMENT 0001213900-21-044732 333-256875 211205066 33 45431753 1 1
2021-08-24 CORRESP filename1.htm 0001213900-21-044643 8217
2021-08-24 SEC STAFF LETTER filename1.pdf 9999999997-21-004583 276092
2021-08-20 CORRESP filename1.htm 0001213900-21-044103 11450
2021-08-20 S-4/A REGISTRATION STATEMENT 0001213900-21-044097 333-256875 211194580 33 46172422 1 1
2021-08-17 UPLOAD filename1.pdf 0000000000-21-010049 44641
2021-08-16 10-Q QUARTERLY REPORT 0001213900-21-043115 001-39138 211179566 34 3129542 1 1
2021-08-09 S-4/A REGISTRATION STATEMENT 0001213900-21-040851 333-256875 211154381 33 37869873 1
2021-08-06 CORRESP filename1.htm 0001213900-21-040853 16701
2021-08-05 UPLOAD filename1.pdf 0000000000-21-009606 39887
2021-08-03 UPLOAD filename1.pdf 0000000000-21-009531 46038
2021-07-23 10-Q/A AMENDMENT NO. 2 TO FORM 10-Q 0001213900-21-038236 001-39138 211108825 34 90394
2021-07-22 CORRESP filename1.htm 0001213900-21-038237 11341
2021-07-22 UPLOAD filename1.pdf 0000000000-21-009061 43009

Latest XBRL company facts

One latest value per concept from companyfacts (477 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.11M 2026-11-10 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
dei EntityPublicFloat Entity Public Float USD 74.80M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001213900-26-050178
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD -2.08M 2025-01-01 2025-12-31 DEF 14A 2026-06-15 0001213900-26-068765
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.37M 2025-01-01 2025-12-31 DEF 14A 2026-06-15 0001213900-26-068765
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -3.54M 2025-01-01 2025-12-31 DEF 14A 2026-06-15 0001213900-26-068765
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.49M 2025-01-01 2025-12-31 DEF 14A 2026-06-15 0001213900-26-068765
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD -77 2025-01-01 2025-12-31 DEF 14A 2026-06-15 0001213900-26-068765
ffd NetFeeAmt NetFeeAmt USD 13,837.11 2026-10-13 S-3 2026-10-14 0001213900-26-109479
ffd TtlFeeAmt TtlFeeAmt USD 13,837.11 2026-10-13 S-3 2026-10-14 0001213900-26-109479
ffd TtlOfferingAmt TtlOfferingAmt USD 159.05M 2026-10-13 S-3 2026-10-14 0001213900-26-109479
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-13 S-3 2026-10-14 0001213900-26-109479
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-13 S-3 2026-10-14 0001213900-26-109479
ffd TtlTxValtn TtlTxValtn USD 4.00M 2026-10-07 SC TO-I 2026-10-07 0001213900-26-107397
us-gaap AccountsNotesAndLoansReceivableNetCurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Current USD 8.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 103,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 10.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.76M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 8.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 200,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 5.50M 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.50M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058660
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 400,000 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 24,000 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AccumulatedCapitalizedInterestCosts Accumulated Capitalized Interest Costs USD 135.50M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AdditionalLiabilityLongDurationInsuranceReinsuranceRecoverableAfterAllowance AdditionalLiabilityLongDurationInsuranceReinsuranceRecoverableAfterAllowance USD 400,000 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 324.81M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 9,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.19M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 725,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap AdvanceRoyalties Advance Royalties USD 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.19M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 100,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 846,591 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AreaOfLand Area of Land sqft 25,900 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap Assets Assets USD 147.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AssetsCurrent Assets, Current USD 147.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 102.87M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 100.34M 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap AssetsNet Net Assets USD 600,000 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 5.30M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap BusinessAcquisitionSharePrice Business Acquisition, Share Price USD/shares 9.2 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 5.00M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage pure 0.6 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 170,000 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 90,000 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap CapitalUnitsOutstanding Capital Units, Outstanding shares 1.18M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap Cash Cash USD 700,000 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 135.35M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 1.00M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -155,560 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-012038
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 135.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 106.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -460,384 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 115.81M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 10 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075635
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 675,000 2025-09-30 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 20.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.04 2018-03-01 2018-03-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 2.26M 2018-03-01 2018-03-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap CommonStockHeldBySubsidiary Common Stock Held by Subsidiary USD 30.00M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 15.12 2021-09-24 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 5.00M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 492.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 110.80M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CommonUnitIssued Common Unit, Issued shares 12,999 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 12,953 2026-07-16 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.34M 2023-01-31 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 61 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap CostMaintenance Cost, Maintenance USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CostOfRevenue Cost of Revenue USD 11.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap CreditDerivativeLiquidationProceedsPercentage Credit Derivative, Liquidation Proceeds, Percentage pure 0.6 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001213900-20-036217
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 38,451 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -48,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001213900-20-036217
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 300,000 2019-08-23 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.09 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 0.08 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DeferredCompensationArrangementWithIndividualCompensationExpense Deferred Compensation Arrangement with Individual, Compensation Expense USD 986,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 193,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -14.97M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 444,772 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 105,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredLongTermLiabilityCharges Deferred Long-term Liability Charges USD 600,000 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 75.00M 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 327,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap DeferredRevenue Deferred Revenue USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 286,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 77.80M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 7.08M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 19.11M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 12,389 2019-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007505
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 105,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 48.71M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 1.00M 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 600,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 614,000 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 21,000 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 4.52M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.10M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 542,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.30M 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.37M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 242,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 16.20M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 2.70M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 28,000 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 13,000 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds USD 4.50M 2023-01-31 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap Deposits Deposits USD 100,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058660
us-gaap Depreciation Depreciation USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.11M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 18,000 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap DerivativeCashReceivedOnHedge Derivative, Cash Received on Hedge USD 6,000 2018-03-01 2018-03-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 735,000 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap DerivativeInstrumentsInHedgesLiabilitiesAtFairValue Derivative Instruments in Hedges, Liabilities, at Fair Value USD 4.30M 2019-11-30 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DerivativeLiabilities Derivative Liability USD 8.16M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 2.26M 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap DirectTaxesAndLicensesCosts Cost, Direct Tax and License USD 25,000 2023-03-01 2023-03-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap DisaggregationOfIncomeStatementExpenseCaptionReimbursementToAnotherEntityAmount DisaggregationOfIncomeStatementExpenseCaptionReimbursementToAnotherEntityAmount USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap DividendsStock Dividends, Stock USD 2.659 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DueToEmployeesCurrentAndNoncurrent Due to Employees USD 74,000 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap DueToOtherRelatedPartiesNoncurrent Due to Other Related Parties, Noncurrent USD 6,000 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -14.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.69 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -14.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.006 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.235 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.192 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.8 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 100,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 95,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 100,000 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 100,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation Employee Stock Ownership Plan (ESOP), Fair Value of Shares Subject to Repurchase Obligation USD 855,173 2023-04-01 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent USD 200,000 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap EquipmentExpense Equipment Expense USD 1.71M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 700,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.099 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025945
us-gaap EquityMethodInvestmentQuotedMarketValue Equity Method Investment, Quoted Market Value USD 200,000 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 263.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 490.00M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 9.00M 2023-01-31 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ExcessStockSharesOutstanding Excess Stock, Shares Outstanding shares 1.70M 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025945
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -12.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 28,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 105,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 502,000 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap GainLossOnFairValueHedgesRecognizedInEarnings Gain (Loss) on Fair Value Hedges Recognized in Earnings USD 100,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 100,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 1.90M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 1.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 1.93M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap IncomeTaxesPaid Income Taxes Paid USD 5,170 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 250,000 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 17.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 32,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -15.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 26,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 1.63M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncomeTaxReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount USD -2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -663,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -6.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 59,477 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD -663,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 56,628 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 3.50M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -911,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001213900-22-047382
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -32,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -143,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -80,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -663,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -11.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.36M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -1.47M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD 5,071 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap InterestAndOtherIncome Interest and Other Income USD 2.53M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap InterestCostsIncurred Interest Costs Incurred USD 300,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -246,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap InterestIncomeOther Interest Income, Other USD 1.39M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap InterestIncomeSecuritiesTaxable Interest Income, Securities, Operating, Taxable USD 2.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.25 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LeaseCost Lease, Cost USD 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 2.48M 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 71,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 743,000 2022-12-31 2022 Q2 10-Q 2022-08-12 0001213900-22-047382
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 32,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 743,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 740,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 740,000 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 740,000 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 39,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap Liabilities Liabilities USD 20.89M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 147.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LiabilitiesCurrent Liabilities, Current USD 13.91M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 18,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 600,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap LoansAndLeasesReceivableAllowance Loans and Leases Receivable, Allowance USD 1.20M 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1.97M 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 3.40M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 100.13M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 102.87M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 125.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 7.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -148.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NetIncomeLossAttributableToNonredeemableNoncontrollingInterest Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest USD 1.93M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 24.50M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -47.96M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075635
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -30.34M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD -6.48M 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax USD/shares -1.03 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 16,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap NondebtorReorganizationItemsLegalAndAdvisoryProfessionalFees Nondebtor Reorganization Items, Legal and Advisory Professional Fees USD 300,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001213900-22-047382
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 300,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075635
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 15.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 183,876 2019-08-23 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056595
us-gaap OfferingCostsPartnershipInterests Offering Costs, Partnership Interests USD 5.71M 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028790
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 172.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingExpenses Operating Expenses USD 172.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -164.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseCost Operating Lease, Cost USD 609,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 400,000 2025-12-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 1.12M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 69,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 69,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 724,000 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 67,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 201,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.093 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 2.90M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap OptionContractIndexedToEquitySettlementCashEffectOfChangeInFairValueOfShare OptionContractIndexedToEquitySettlementCashEffectOfChangeInFairValueOfShare USD 100,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap OptionContractIndexedToEquitySettlementShareFairValue OptionContractIndexedToEquitySettlementShareFairValue USD 1.50M 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 102,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 0 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 100,000 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 1.10M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherAssetsCurrent Other Assets, Current USD 636,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherCashEquivalentsAtCarryingValue Other Cash Equivalents, at Carrying Value USD 1.00M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 400,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 500,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 1.81M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap OtherIncome Other Income USD 2.30M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 5.00M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap OtherInterestEarningAssets Other Interest Earning Assets USD 198,343 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap OtherLiabilities Other Liabilities USD 28,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap OtherLiabilitiesAndDeferredRevenueNoncurrent Other Liabilities and Deferred Revenue, Noncurrent USD 80,000 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 392,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 18,000 2022-12-31 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap OtherNoncashExpense Other Noncash Expense USD 458,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -116,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 62,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-067897
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4,971 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 2.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 23.60M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 249,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095173
us-gaap OtherReceivables Other Receivables USD 30.00M 2026-07-16 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 663,000 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 1.70M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 3.50M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap PaymentsForFees Payments for Other Fees USD 50.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap PaymentsForRent Payments for Rent USD 26,000 2022-07-01 2022-07-22 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock Payments for Repurchase of Redeemable Convertible Preferred Stock USD 6.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PaymentsForRepurchaseOfRedeemablePreferredStock Payments for Repurchase of Redeemable Preferred Stock USD 600 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PaymentsForRoyalties Payments for Royalties USD 8.30M 2024-12-01 2024-12-31 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 2.00M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 235,896 2019-08-13 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 400,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 960,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -7.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 100.00M 2019-08-13 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD -77,310 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-012038
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 21.72M 2021-09-24 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap PreferredStockDividendsShares Preferred Stock Dividends, Shares shares 10.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 0.25 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 2.659 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 93,409 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028790
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-03-31 2021 Q1 10-Q 2021-05-24 0001213900-21-028790
us-gaap PreferredUnitsAuthorized Preferred Units, Authorized shares 4.51M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 2.82M 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 205,986 2020-09-30 2020 Q3 10-Q 2020-11-10 0001213900-20-036217
us-gaap PrepaidInsurance Prepaid Insurance USD 325,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PrepaidRent Prepaid Rent USD 27,000 2021-12-31 2022 Q2 10-Q 2022-08-12 0001213900-22-047382
us-gaap PrepaidTaxes Prepaid Taxes USD 9,620 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 100.00M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001213900-20-036217
us-gaap ProceedsFromHedgeFinancingActivities Proceeds from Hedge, Financing Activities USD 95.27M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 3.30M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001213900-24-067897
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 6.45M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 10.75M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 4.00M 2019-08-13 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 132.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 64,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 725,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.07M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -183,876 2019-08-13 2019-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007505
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ProceedsFromSaleOfTreasuryStock Proceeds from Sale of Treasury Stock USD 150.00M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 329,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap ProductionAndDistributionCosts Production and Distribution Costs USD 1.70M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 100,000 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095173
us-gaap ProfessionalFees Professional Fees USD 200,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 30.30M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.61M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 43.84M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap RelatedPartyCosts Related Party Costs USD 7,050 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 44,364 2019-08-13 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.05 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 183,876 2019-08-13 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount pure 1 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 19.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 2.30M 2020-11-01 2020-11-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost Research and Development Expense, Software (Excluding Acquired in Process Cost) USD 9.00M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 1.42M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap RestrictedCash Restricted Cash USD 417,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 116.23M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 417,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 417,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 31.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -960,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 2.30M 2020-11-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.5 2025-07-01 2025-07-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap RestructuringCosts Restructuring Costs USD 2.30M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 25.53M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075635
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -465.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 9.00M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap Revenues Revenues USD 8.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.09M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 10.00M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 69.00M 2023-01-31 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap SalesTypeLeaseRevenue Sales-type Lease, Revenue USD 8.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap SeveranceCosts1 Severance Costs USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 2.66M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.1 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date pure 0.008 2020-07-27 2021-02-26 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 94,972 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025945
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value USD/shares 541,225 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.10M 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039021
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share USD/shares 35 2024-06-01 2024-06-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 6.60M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 400,000 2024-06-01 2024-06-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 23.95 2024-06-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.33 2024-06-01 2024-06-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.049 2024-06-01 2024-06-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 262,619 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 468,115 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 721,955 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107884
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 202,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 313,959 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.78 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 500,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 16,650 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 50,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.54 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025945
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 94,972 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025945
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 6.30M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001213900-22-047382
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 27 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 400,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 417,231 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.45 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 202,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 9.40M 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 202,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 497,309 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 1.45 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 900,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056595
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.33 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056595
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 65,001 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.71 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.92 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.92 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.72M 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap SharePrice Share Price USD/shares 7.9 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap SharesIssued Shares, Issued shares 10 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.003 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 169,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 1,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap StockDividendsShares Stock Dividends, Shares shares 4.52M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 2.49M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071165
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -140.25M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 101.79M 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-012038
us-gaap StockIssued1 Stock Issued USD 4.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 900,000 2023-01-31 2024 FY 10-K 2025-02-28 0001213900-25-018384
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 4.66M 2026-07-16 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 499,986 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001213900-25-075635
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 1.08M 2023-10-01 2023-10-31 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 200,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 4.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 94.06M 2019-08-13 2019-12-31 2019 FY 10-K 2020-03-26 0001213900-20-007505
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.87M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 150.00M 2022-10-01 2022-10-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 1,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-084970
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 329,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -3.57M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap TaxCreditCarryforwardValuationAllowance Tax Credit Carryforward, Valuation Allowance USD 77.69M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 16,225 2019-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 81.29M 2021-06-30 2021 Q2 10-Q 2021-08-16 0001213900-21-043115
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 41.16M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 18 2020-12-31 2020 FY 10-K/A 2021-05-24 0001213900-21-028779
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 19.52M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 15.48M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 15.48M 2020-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap TenantImprovements Tenant Improvements USD 1.50M 2023-12-31 2023 FY 10-K 2024-03-05 0001213900-24-020114
us-gaap UnamortizedDiscountsOnAcceptancesExecuted Unamortized Discounts on Acceptances Executed USD 500,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 3.68M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 709,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap UnrecordedUnconditionalPurchaseObligationImputedInterest Unrecorded Unconditional Purchase Obligation, Imputed Interest USD 412,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 16.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap VariableLeaseCost Variable Lease, Cost USD 535,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 3.78M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 99.78M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-066234
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 28.68M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-089592
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted Weighted Average Number of Limited Partnership and General Partnership Unit Outstanding, Basic and Diluted shares 36.48M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001213900-23-018542
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 11.39M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-18 0001213900-22-013592
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 76,598 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036426
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 22,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120161
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 7,256 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001213900-25-018384

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →